Where do we find these numbers Hotdog? Some of the costs seem a bit high, particularly at scale. The way I think of Striate+ is more of a nice to have product which will give us a cash bridge to achieve our core products focused on regenerating mobility.
These biotechs can be a real rollercoaster in share price and performance. It can take a long time to produce results (typically decades). If you are so distressed mate and your sentiment is sell, maybe you should consider cutting your losses and move on. Its just not worth the damage to your mental health.
OCC Trading, page-1395
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.49M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.5¢ | $11.69K | 31.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 449964 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 11502 | 3 |
View Market Depth
| Last trade - 15.59pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
37.5¢ |
Change
0.000 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| 38.0¢ | 38.0¢ | 37.5¢ | 22028 | ||
| Last updated 14.08pm 21/05/2024 ? | |||||
| OCC (ASX) Chart |